Back to Awarded Treatment Trials


Awarded Trial: 12T-004

Grant ID

12T-004

Illness

schizophrenia

Primary Drug/Intervention

tocilizumab

Primary Dosage

4mg/kg and 8mg/kg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Girgis

Sample Size

36

Duration of Study Period for Each Subject

90 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Ragy Girgis

Degree

MD

Center

New York State Psychiatric Institute

Institution

Columbia University

Address

1051 Riverside Drive, Unit 31

City or Town

New York

State or Province

NY

Zip or Postal Code

10032

Country

USA

Email Address

ragygir@nyspi.columbia.edu